Monday, May 6, 2013

• Dynavax Reports First Quarter 2013 Financial ResultsMarketwired( (Mon, May 6)

Tuesday, April 30, 2013

• Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of DirectorsMarketwired( (Tue, Apr 30)

Thursday, March 21, 2013

• Dynavax Appoints David Novack as Senior Vice President, Operations and QualityMarketwired( (Thu, Mar 21)

Friday, March 1, 2013

• Dynavax Reports Fourth Quarter and Year End 2012 Financial ResultsMarketwired( (Fri, Mar 1)

Tuesday, February 26, 2013

• Dynavax to Present at the Cowen and Company 33rd Annual Healthcare ConferenceMarketwired( (Tue, Feb 26)

Monday, February 25, 2013

• Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License ApplicationMarketwired( (Mon, Feb 25)

Monday, January 28, 2013

• Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on HandMarketwired( (Mon, Jan 28)

Monday, December 17, 2012

• Dynavax to Present at the 31st Annual J.P. Morgan Healthcare ConferenceMarketwired( (Mon, Dec 17)

Thursday, November 15, 2012

• Dynavax Announces FDA Advisory Committee Meeting Outcome for HEPLISAV(TM)Marketwired( (Thu, Nov 15)
• Biotech Industry Experiencing More FDA New Drug Approvals in 2012Marketwired( (Thu, Nov 15)

Thursday, November 1, 2012

• Dynavax Reports Third Quarter 2012 Financial ResultsMarketwired( (Thu, Nov 1)

Wednesday, October 31, 2012

• Dynavax to Initiate Phase 1 Studies for TLR-9 Agonist for AsthmaMarketwired( (Wed, Oct 31)

Tuesday, September 18, 2012

• New Legislation Passed to Help Speed Up FDA Review ProcessMarketwired( (Tue, Sep 18)